Loading data for TTRX — first visit, this takes a few seconds.
Turn Therapeutics Inc. (TTRX)
NasdaqGM: TTRX
· Real-Time Price · USD
9.80
-0.27 (-2.68%)
At close: Sep 09, 2026, 8:00 PM
The price, the headline numbers and the latest news, in one place.
Turn Therapeutics Inc. (TTRX) Stock Price, Analysis & Data
No data available
| Bid | 7.65 |
| Market Cap | 418M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -8.45M |
| 0.00 | |
| -0.31 | |
| n/a | |
| -91.67 | |
| P/B (ttm) | 597.83 |
| P/S (ttm) | 0.00 |
| Earnings Date | Nov 12, 2026 |
| Ask | 7.37 |
| Volume | 70,574 |
| Avg. Volume (20D) | 77,509 |
| Open | 9.94 |
| Previous Close | 10.07 |
| Day's Range | 9.70 - 10.50 |
| 52-Week Range | 2.57 - 26.50 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About TTRX
Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global ...
Industry Biotechnology
Sector Healthcare
IPO Date Oct 8, 2025
Employees 2
Stock Exchange NasdaqGM
Ticker Symbol TTRX
Website https://turntherapeutics.com
Financial Performance
In 2025, Turn Therapeutics's revenue was 0, an increase of undefined% compared to the previous year's 0. Earnings were -3.19M, an increase of 80.62%.
Financial StatementsEarnings Surprise
Turn Therapeutics has released their quarterly earnings on Aug 12, 2026:
- Revenue of n/a misses estimates by $0, with NaN% YoY growth.
- EPS of -0.2 misses estimates by -0.18, with -Infinity% YoY decline.
Turn Therapeutics Inc. is scheduled to release its earnings on Nov 12, 2026, during market hours.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2